{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:41:06Z","timestamp":1792723266861,"version":"4.5.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/nm.2507","type":"journal-article","created":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T17:17:04Z","timestamp":1320686224000},"page":"1391-1401","source":"Crossref","is-referenced-by-count":3066,"title":["Ischemia and reperfusion\u2014from mechanism to translation"],"prefix":"10.1038","volume":"17","author":[{"given":"Holger K","family":"Eltzschig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Eckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,7]]},"reference":[{"key":"BFnm2507_CR1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon, D.M. & Hausenloy, D.J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121\u20131135 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2507_CR2","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/CIRCULATIONAHA.105.556746","volume":"112","author":"S Ryan","year":"2005","unstructured":"Ryan, S., Taylor, C.T. & McNicholas, W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112, 2660\u20132667 (2005).","journal-title":"Circulation"},{"key":"BFnm2507_CR3","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1182\/blood-2010-06-290643","volume":"116","author":"KL Wallace","year":"2010","unstructured":"Wallace, K.L. & Linden, J. Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood 116, 5010\u20135020 (2010).","journal-title":"Blood"},{"key":"BFnm2507_CR4","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.24253","volume":"53","author":"SW Park","year":"2011","unstructured":"Park, S.W., Kim, M., Brown, K.M., D'Agati, V.D. & Lee, H.T. Paneth cell\u2013derived IL-17A causes multi-organ dysfunction after hepatic ischemia and reperfusion injury. Hepatology 53, 1662\u20131675 (2011).","journal-title":"Hepatology"},{"key":"BFnm2507_CR5","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI114540","volume":"85","author":"S Ogawa","year":"1990","unstructured":"Ogawa, S. et al. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J. Clin. Invest. 85, 1090\u20131098 (1990).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR6","doi-asserted-by":"crossref","first-page":"C546","DOI":"10.1152\/ajpcell.1992.262.3.C546","volume":"262","author":"S Ogawa","year":"1992","unstructured":"Ogawa, S. et al. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am. J. Physiol. 262, C546\u2013C554 (1992).","journal-title":"Am. J. Physiol."},{"key":"BFnm2507_CR7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJMra0901217","volume":"361","author":"RS Hotchkiss","year":"2009","unstructured":"Hotchkiss, R.S., Strasser, A., McDunn, J.E. & Swanson, P.E. Cell death. N. Engl. J. Med. 361, 1570\u20131583 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2507_CR8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig, H.K. & Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 364, 656\u2013665 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2507_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0065-2776(04)86004-8","volume":"86","author":"MC Carroll","year":"2005","unstructured":"Carroll, M.C. & Holers, V.M. Innate autoimmunity. Adv. Immunol. 86, 137\u2013157 (2005).","journal-title":"Adv. Immunol."},{"key":"BFnm2507_CR10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen, G.Y. & Nunez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826\u2013837 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm2507_CR11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola, C. & Anrather, J. The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796\u2013808 (2011).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR12","doi-asserted-by":"crossref","first-page":"20388","DOI":"10.1073\/pnas.0908698106","volume":"106","author":"SS Iyer","year":"2009","unstructured":"Iyer, S.S. et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. USA 106, 20388\u201320393 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2507_CR13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.1195491","volume":"330","author":"B McDonald","year":"2010","unstructured":"McDonald, B. et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330, 362\u2013366 (2010).","journal-title":"Science"},{"key":"BFnm2507_CR14","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1089\/ars.2010.3665","volume":"15","author":"A Grenz","year":"2011","unstructured":"Grenz, A., Homann, D. & Eltzschig, H.K. Extracellular adenosine\u2014a \u201csafety signal\u201d that dampens hypoxia-induced inflammation during ischemia. Antioxid. Redox Signal. 15, 2221\u20132234 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"BFnm2507_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm1198","volume":"11","author":"P Petzelbauer","year":"2005","unstructured":"Petzelbauer, P. et al. The fibrin-derived peptide B\u03b215\u201342 protects the myocardium against ischemia-reperfusion injury. Nat. Med. 11, 298\u2013304 (2005).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/76048","volume":"25","author":"NC Arbour","year":"2000","unstructured":"Arbour, N.C. et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25, 187\u2013191 (2000).","journal-title":"Nat. Genet."},{"key":"BFnm2507_CR17","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20060943","volume":"203","author":"KA Powers","year":"2006","unstructured":"Powers, K.A. et al. Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J. Exp. Med. 203, 1951\u20131961 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnm2507_CR18","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI31008","volume":"117","author":"H Wu","year":"2007","unstructured":"Wu, H. et al. TLR4 activation mediates kidney ischemia\/reperfusion injury. J. Clin. Invest. 117, 2847\u20132859 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR19","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1073\/pnas.0810169106","volume":"106","author":"B Kr\u00fcger","year":"2009","unstructured":"Kr\u00fcger, B. et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. USA 106, 3390\u20133395 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2507_CR20","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1084\/jem.20081370","volume":"205","author":"KA Cavassani","year":"2008","unstructured":"Cavassani, K.A. et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 205, 2609\u20132621 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnm2507_CR21","doi-asserted-by":"crossref","first-page":"e1364","DOI":"10.1371\/journal.pone.0001364","volume":"2","author":"J Kuhlicke","year":"2007","unstructured":"Kuhlicke, J., Frick, J.S., Morote-Garcia, J.C., Rosenberger, P. & Eltzschig, H.K. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS ONE 2, e1364 (2007).","journal-title":"PLoS ONE"},{"key":"BFnm2507_CR22","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4049\/jimmunol.168.3.1286","volume":"168","author":"TG Wolfs","year":"2002","unstructured":"Wolfs, T.G. et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-g and TNF-a mediated up-regulation during inflammation. J. Immunol. 168, 1286\u20131293 (2002).","journal-title":"J. Immunol."},{"key":"BFnm2507_CR23","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1172\/JCI22832","volume":"115","author":"JC Leemans","year":"2005","unstructured":"Leemans, J.C. et al. Renal-associated TLR2 mediates ischemia\/reperfusion injury in the kidney. J. Clin. Invest. 115, 2894\u20132903 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm1589","volume":"13","author":"H Kanzler","year":"2007","unstructured":"Kanzler, H., Barrat, F.J., Hessel, E.M. & Coffman, R.L. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13, 552\u2013559 (2007).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR25","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/ALN.0b013e31820b8b44","volume":"114","author":"J Fenhammar","year":"2011","unstructured":"Fenhammar, J. et al. Toll-like receptor 4 inhibitor TAK-242 attenuates acute kidney injury in endotoxemic sheep. Anesthesiology 114, 1130\u20131137 (2011).","journal-title":"Anesthesiology"},{"key":"BFnm2507_CR26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","volume":"38","author":"TW Rice","year":"2010","unstructured":"Rice, T.W. et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit. Care Med. 38, 1685\u20131694 (2010).","journal-title":"Crit. Care Med."},{"key":"BFnm2507_CR27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski, F.K. et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612\u2013616 (2009).","journal-title":"Science"},{"key":"BFnm2507_CR28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1172\/JCI40008","volume":"120","author":"ZM Bamboat","year":"2010","unstructured":"Bamboat, Z.M. et al. Conventional DCs reduce liver ischemia\/reperfusion injury in mice via IL-10 secretion. J. Clin. Invest. 120, 559\u2013569 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2353\/ajpath.2008.080019","volume":"173","author":"P Pacher","year":"2008","unstructured":"Pacher, P. & Szabo, C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am. J. Pathol. 173, 2\u201313 (2008).","journal-title":"Am. J. Pathol."},{"key":"BFnm2507_CR30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI42596","volume":"121","author":"D Kreisel","year":"2011","unstructured":"Kreisel, D. et al. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis. J. Clin. Invest. 121, 265\u2013276 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.4049\/jimmunol.0801928","volume":"183","author":"SR Satpute","year":"2009","unstructured":"Satpute, S.R. et al. The role for T cell repertoire\/antigen-specific interactions in experimental kidney ischemia reperfusion injury. J. Immunol. 183, 984\u2013992 (2009).","journal-title":"J. Immunol."},{"key":"BFnm2507_CR32","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.23153","volume":"50","author":"X Shen","year":"2009","unstructured":"Shen, X. et al. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia\/reperfusion injury. Hepatology 50, 1537\u20131546 (2009).","journal-title":"Hepatology"},{"key":"BFnm2507_CR33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-5728(94)90010-8","volume":"55","author":"M Schroeter","year":"1994","unstructured":"Schroeter, M., Jander, S., Witte, O.W. & Stoll, G. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J. Neuroimmunol. 55, 195\u2013203 (1994).","journal-title":"J. Neuroimmunol."},{"key":"BFnm2507_CR34","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.105.593046","volume":"113","author":"G Yilmaz","year":"2006","unstructured":"Yilmaz, G., Arumugam, T.V., Stokes, K.Y. & Granger, D.N. Role of T lymphocytes and interferon-g in ischemic stroke. Circulation 113, 2105\u20132112 (2006).","journal-title":"Circulation"},{"key":"BFnm2507_CR35","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.0000163586.62253.A5","volume":"111","author":"Z Yang","year":"2005","unstructured":"Yang, Z. et al. Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation 111, 2190\u20132197 (2005).","journal-title":"Circulation"},{"key":"BFnm2507_CR36","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.4049\/jimmunol.176.5.3108","volume":"176","author":"YJ Day","year":"2006","unstructured":"Day, Y.J. et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-g. J. Immunol. 176, 3108\u20133114 (2006).","journal-title":"J. Immunol."},{"key":"BFnm2507_CR37","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.1999","volume":"15","author":"T Shichita","year":"2009","unstructured":"Shichita, T. et al. Pivotal role of cerebral interleukin-17-producing \u03b3\u03b4 T cells in the delayed phase of ischemic brain injury. Nat. Med. 15, 946\u2013950 (2009).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-3083.2005.01683.x","volume":"62","author":"GZ Li","year":"2005","unstructured":"Li, G.Z. et al. Expression of interleukin-17 in ischemic brain tissue. Scand. J. Immunol. 62, 481\u2013486 (2005).","journal-title":"Scand. J. Immunol."},{"key":"BFnm2507_CR39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.1927","volume":"15","author":"A Liesz","year":"2009","unstructured":"Liesz, A. et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15, 192\u2013199 (2009).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR40","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nm.2154","volume":"16","author":"SN Nadig","year":"2010","unstructured":"Nadig, S.N. et al. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat. Med. 16, 809\u2013813 (2010).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR41","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","volume":"5","author":"S Floess","year":"2007","unstructured":"Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38 (2007).","journal-title":"PLoS Biol."},{"key":"BFnm2507_CR42","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","volume":"13","author":"R Tao","year":"2007","unstructured":"Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299\u20131307 (2007).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR43","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.4049\/jimmunol.0803980","volume":"182","author":"L Kulik","year":"2009","unstructured":"Kulik, L. et al. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J. Immunol. 182, 5363\u20135373 (2009).","journal-title":"J. Immunol."},{"key":"BFnm2507_CR44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.20050390","volume":"203","author":"M Zhang","year":"2006","unstructured":"Zhang, M. et al. Identification of the target self-antigens in reperfusion injury. J. Exp. Med. 203, 141\u2013152 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnm2507_CR45","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785\u2013797 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnm2507_CR46","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/SLA.0b013e3181a38f45","volume":"249","author":"GM Diepenhorst","year":"2009","unstructured":"Diepenhorst, G.M., van Gulik, T.M. & Hack, C.E. Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann. Surg. 249, 889\u2013899 (2009).","journal-title":"Ann. Surg."},{"key":"BFnm2507_CR47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.17.1881-b","volume":"297","author":"PW Armstrong","year":"2007","unstructured":"Armstrong, P.W. et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. J. Am. Med. Assoc. 297, 43\u201351 (2007).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnm2507_CR48","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.athoracsur.2003.08.054","volume":"77","author":"SK Shernan","year":"2004","unstructured":"Shernan, S.K. et al. Impact of pexelizumab, an anti\u2013C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass. Ann. Thorac. Surg. 77, 942\u2013949, discussion 949\u2013950 (2004).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnm2507_CR49","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.291.19.2319","volume":"291","author":"ED Verrier","year":"2004","unstructured":"Verrier, E.D. et al. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. J. Am. Med. Assoc. 291, 2319\u20132327 (2004).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnm2507_CR50","first-page":"2304","volume":"119","author":"S He","year":"2009","unstructured":"He, S. et al. A complement-dependent balance between hepatic ischemia\/reperfusion injury and liver regeneration in mice. J. Clin. Invest. 119, 2304\u20132316 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm1722","volume":"14","author":"M Moser","year":"2008","unstructured":"Moser, M., Nieswandt, B., Ussar, S., Pozgajova, M. & F\u00e4ssler, R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat. Med. 14, 325\u2013330 (2008).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR52","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1172\/JCI35874","volume":"118","author":"T Weissm\u00fcller","year":"2008","unstructured":"Weissm\u00fcller, T. et al. PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J. Clin. Invest. 118, 3682\u20133692 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR53","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2009.11.001","volume":"139","author":"F M\u00fcller","year":"2009","unstructured":"M\u00fcller, F. et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139, 1143\u20131156 (2009).","journal-title":"Cell"},{"key":"BFnm2507_CR54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1617146","volume":"30","author":"J Xu","year":"2010","unstructured":"Xu, J., Lupu, F. & Esmon, C.T. Inflammation, innate immunity and blood coagulation. Hamostaseologie 30, 5\u20136, 8\u20139 (2010).","journal-title":"Hamostaseologie"},{"key":"BFnm2507_CR55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/BST0330401","volume":"33","author":"CT Esmon","year":"2005","unstructured":"Esmon, C.T. Coagulation inhibitors in inflammation. Biochem. Soc. Trans. 33, 401\u2013405 (2005).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnm2507_CR56","doi-asserted-by":"crossref","first-page":"e5391","DOI":"10.1371\/journal.pone.0005391","volume":"4","author":"M Groger","year":"2009","unstructured":"Groger, M. et al. Peptide B\u03b215\u201342 preserves endothelial barrier function in shock. PLoS One 4, e5391 (2009).","journal-title":"PLoS One"},{"key":"BFnm2507_CR57","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2008.12.017","volume":"53","author":"D Atar","year":"2009","unstructured":"Atar, D. et al. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (efficacy of FX06 in the prevention of myocardial reperfusion injury) trial. J. Am. Coll. Cardiol. 53, 720\u2013729 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnm2507_CR58","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","volume":"461","author":"MR Elliott","year":"2009","unstructured":"Elliott, M.R. et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461, 282\u2013286 (2009).","journal-title":"Nature"},{"key":"BFnm2507_CR59","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nature09413","volume":"467","author":"FB Chekeni","year":"2010","unstructured":"Chekeni, F.B. et al. Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 467, 863\u2013867 (2010).","journal-title":"Nature"},{"key":"BFnm2507_CR60","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1172\/JCI25461","volume":"115","author":"CV Thakar","year":"2005","unstructured":"Thakar, C.V. et al. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J. Clin. Invest. 115, 3451\u20133459 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR61","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.20091704","volume":"207","author":"Z Tang","year":"2010","unstructured":"Tang, Z. et al. Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3b phosphorylation. J. Exp. Med. 207, 867\u2013880 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnm2507_CR62","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1074\/jbc.M605178200","volume":"282","author":"MH Liang","year":"2007","unstructured":"Liang, M.H. & Chuang, D.M. Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. J. Biol. Chem. 282, 3904\u20133917 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnm2507_CR63","doi-asserted-by":"crossref","first-page":"18154","DOI":"10.1073\/pnas.0602235103","volume":"103","author":"EP Cummins","year":"2006","unstructured":"Cummins, E.P. et al. Prolyl hydroxylase-1 negatively regulates IkB kinase-b, giving insight into hypoxia-induced NFkB activity. Proc. Natl. Acad. Sci. USA 103, 18154\u201318159 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2507_CR64","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.284.5412.321","volume":"284","author":"Q Li","year":"1999","unstructured":"Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F. & Verma, I.M. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284, 321\u2013325 (1999).","journal-title":"Science"},{"key":"BFnm2507_CR65","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm849","volume":"9","author":"LW Chen","year":"2003","unstructured":"Chen, L.W. et al. The two faces of IKK and NF-\u03baB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9, 575\u2013581 (2003).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR66","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJMoa071142","volume":"359","author":"C Piot","year":"2008","unstructured":"Piot, C. et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 359, 473\u2013481 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2507_CR67","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMe0803746","volume":"359","author":"DJ Hausenloy","year":"2008","unstructured":"Hausenloy, D.J. & Yellon, D.M. Time to take myocardial reperfusion injury seriously. N. Engl. J. Med. 359, 518\u2013520 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2507_CR68","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1074\/jbc.M800102200","volume":"283","author":"H Zhang","year":"2008","unstructured":"Zhang, H. et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 283, 10892\u201310903 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnm2507_CR69","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1161\/CIRCULATIONAHA.109.928242","volume":"122","author":"JA Sala-Mercado","year":"2010","unstructured":"Sala-Mercado, J.A. et al. Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation 122, S179\u2013S184 (2010).","journal-title":"Circulation"},{"key":"BFnm2507_CR70","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jama.1989.03420070080035","volume":"261","author":"JM Klausner","year":"1989","unstructured":"Klausner, J.M. et al. Reperfusion pulmonary edema. J. Am. Med. Assoc. 261, 1030\u20131035 (1989).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnm2507_CR71","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1164\/rccm.200207-670SO","volume":"167","author":"M de Perrot","year":"2003","unstructured":"de Perrot, M., Liu, M., Waddell, T.K. & Keshavjee, S. Ischemia-reperfusion-induced lung injury. Am. J. Respir. Crit. Care Med. 167, 490\u2013511 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm2507_CR72","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood-2007-10-117044","volume":"111","author":"T Eckle","year":"2008","unstructured":"Eckle, T. et al. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111, 2024\u20132035 (2008).","journal-title":"Blood"},{"key":"BFnm2507_CR73","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1182\/blood-2007-11-126763","volume":"111","author":"JC Morote-Garcia","year":"2008","unstructured":"Morote-Garcia, J.C., Rosenberger, P., Kuhlicke, J. & Eltzschig, H.K. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111, 5571\u20135580 (2008).","journal-title":"Blood"},{"key":"BFnm2507_CR74","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.20040915","volume":"200","author":"LF Thompson","year":"2004","unstructured":"Thompson, L.F. et al. Crucial role for ecto-5\u2032-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200, 1395\u20131405 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnm2507_CR75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.1683","volume":"10","author":"P Rosenberger","year":"2009","unstructured":"Rosenberger, P. et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10, 195\u2013202 (2009).","journal-title":"Nat. Immunol."},{"key":"BFnm2507_CR76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/bmb\/ldh025","volume":"70","author":"HK Eltzschig","year":"2004","unstructured":"Eltzschig, H.K. & Collard, C.D. Vascular ischaemia and reperfusion injury. Br. Med. Bull. 70, 71\u201386 (2004).","journal-title":"Br. Med. Bull."},{"key":"BFnm2507_CR77","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nm.1939","volume":"15","author":"A Hidalgo","year":"2009","unstructured":"Hidalgo, A. et al. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat. Med. 15, 384\u2013391 (2009).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR78","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/nm.2022","volume":"15","author":"M Yemisci","year":"2009","unstructured":"Yemisci, M. et al. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat. Med. 15, 1031\u20131037 (2009).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR79","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.107.758516","volume":"118","author":"T Eckle","year":"2008","unstructured":"Eckle, T., Kohler, D., Lehmann, R., El Kasmi, K.C. & Eltzschig, H.K. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118, 166\u2013175 (2008).","journal-title":"Circulation"},{"key":"BFnm2507_CR80","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.106.669697","volume":"115","author":"T Eckle","year":"2007","unstructured":"Eckle, T. et al. Cardioprotection by ecto-5\u2032-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115, 1581\u20131590 (2007).","journal-title":"Circulation"},{"key":"BFnm2507_CR81","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.107.690180","volume":"116","author":"D K\u00f6hler","year":"2007","unstructured":"K\u00f6hler, D. et al. CD39\/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia\/reperfusion injury. Circulation 116, 1784\u20131794 (2007).","journal-title":"Circulation"},{"key":"BFnm2507_CR82","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/01.sla.0000246834.07130.5d","volume":"244","author":"H Petrowsky","year":"2006","unstructured":"Petrowsky, H. et al. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann. Surg. 244, 921\u2013928, discussion 928\u2013930 (2006).","journal-title":"Ann. Surg."},{"key":"BFnm2507_CR83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.sla.0000167848.96692.ad","volume":"242","author":"D Azoulay","year":"2005","unstructured":"Azoulay, D. et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann. Surg. 242, 133\u2013139 (2005).","journal-title":"Ann. Surg."},{"key":"BFnm2507_CR84","doi-asserted-by":"crossref","first-page":"H2533","DOI":"10.1152\/ajpheart.00472.2006","volume":"291","author":"T Eckle","year":"2006","unstructured":"Eckle, T. et al. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am. J. Physiol. Heart Circ. Physiol. 291, H2533\u2013H2540 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnm2507_CR85","doi-asserted-by":"crossref","first-page":"F475","DOI":"10.1152\/ajprenal.00275.2006","volume":"292","author":"A Grenz","year":"2007","unstructured":"Grenz, A. et al. Use of a hanging-weight system for isolated renal artery occlusion during ischemic preconditioning in mice. Am. J. Physiol. Renal Physiol. 292, F475\u2013F485 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnm2507_CR86","doi-asserted-by":"crossref","first-page":"G1431","DOI":"10.1152\/ajpgi.00083.2008","volume":"294","author":"ML Hart","year":"2008","unstructured":"Hart, M.L. et al. Use of a hanging-weight system for liver ischemic preconditioning in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G1431\u2013G1440 (2008).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnm2507_CR87","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/CIRCULATIONAHA.105.558122","volume":"112","author":"P Staat","year":"2005","unstructured":"Staat, P. et al. Postconditioning the human heart. Circulation 112, 2143\u20132148 (2005).","journal-title":"Circulation"},{"key":"BFnm2507_CR88","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.107.729780","volume":"117","author":"H Thibault","year":"2008","unstructured":"Thibault, H. et al. Long-term benefit of postconditioning. Circulation 117, 1037\u20131044 (2008).","journal-title":"Circulation"},{"key":"BFnm2507_CR89","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","volume":"375","author":"HE B\u00f8tker","year":"2010","unstructured":"B\u00f8tker, H.E. et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375, 727\u2013734 (2010).","journal-title":"Lancet"},{"key":"BFnm2507_CR90","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.1147949","volume":"318","author":"GL Semenza","year":"2007","unstructured":"Semenza, G.L. Life with oxygen. Science 318, 62\u201364 (2007).","journal-title":"Science"},{"key":"BFnm2507_CR91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng.2007.62","volume":"40","author":"J Aragon\u00e9s","year":"2008","unstructured":"Aragon\u00e9s, J. et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40, 170\u2013180 (2008).","journal-title":"Nat. Genet."},{"key":"BFnm2507_CR92","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1681\/ASN.2006090998","volume":"19","author":"P Hill","year":"2008","unstructured":"Hill, P. et al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 19, 39\u201346 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2507_CR93","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1681\/ASN.2010010116","volume":"21","author":"WM Bernhardt","year":"2010","unstructured":"Bernhardt, W.M. et al. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J. Am. Soc. Nephrol. 21, 2151\u20132156 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2507_CR94","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","volume":"136","author":"M Mazzone","year":"2009","unstructured":"Mazzone, M. et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839\u2013851 (2009).","journal-title":"Cell"},{"key":"BFnm2507_CR95","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","volume":"97","author":"ML Brines","year":"2000","unstructured":"Brines, M.L. et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97, 10526\u201310531 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2507_CR96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.CIR.0000078635.89229.8A","volume":"108","author":"Z Cai","year":"2003","unstructured":"Cai, Z. et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108, 79\u201385 (2003).","journal-title":"Circulation"},{"key":"BFnm2507_CR97","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI18200","volume":"112","author":"CJ Parsa","year":"2003","unstructured":"Parsa, C.J. et al. A novel protective effect of erythropoietin in the infarcted heart. J. Clin. Invest. 112, 999\u20131007 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR98","doi-asserted-by":"crossref","first-page":"17531","DOI":"10.1073\/pnas.0608814103","volume":"103","author":"M Fantacci","year":"2006","unstructured":"Fantacci, M. et al. Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia. Proc. Natl. Acad. Sci. USA 103, 17531\u201317536 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2507_CR99","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.2011.592","volume":"305","author":"SS Najjar","year":"2011","unstructured":"Najjar, S.S. et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. J. Am. Med. Assoc. 305, 1863\u20131872 (2011).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnm2507_CR100","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1126\/science.1158554","volume":"321","author":"CH Chen","year":"2008","unstructured":"Chen, C.H. et al. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321, 1493\u20131495 (2008).","journal-title":"Science"},{"key":"BFnm2507_CR101","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nature06504","volume":"451","author":"EJ Miller","year":"2008","unstructured":"Miller, E.J. et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 451, 578\u2013582 (2008).","journal-title":"Nature"},{"key":"BFnm2507_CR102","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI39738","volume":"119","author":"D Qi","year":"2009","unstructured":"Qi, D. et al. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia\/reperfusion. J. Clin. Invest. 119, 3807\u20133816 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR103","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1577","volume":"13","author":"I Ohsawa","year":"2007","unstructured":"Ohsawa, I. et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 13, 688\u2013694 (2007).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR104","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm0607-673","volume":"13","author":"KC Wood","year":"2007","unstructured":"Wood, K.C. & Gladwin, M.T. The hydrogen highway to reperfusion therapy. Nat. Med. 13, 673\u2013674 (2007).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","volume":"7","author":"JO Lundberg","year":"2008","unstructured":"Lundberg, J.O., Weitzberg, E. & Gladwin, M.T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7, 156\u2013167 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm2507_CR106","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1172\/JCI31892","volume":"117","author":"JD Lang Jr.","year":"2007","unstructured":"Lang, J.D. Jr. et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J. Clin. Invest. 117, 2583\u20132591 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR107","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2011.235","volume":"305","author":"MT Gladwin","year":"2011","unstructured":"Gladwin, M.T. et al. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. J. Am. Med. Assoc. 305, 893\u2013902 (2011).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnm2507_CR108","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","volume":"6","author":"C Szab\u00f3","year":"2007","unstructured":"Szab\u00f3, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6, 917\u2013935 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm2507_CR109","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1073\/pnas.0705891104","volume":"104","author":"JW Elrod","year":"2007","unstructured":"Elrod, J.W. et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc. Natl. Acad. Sci. USA 104, 15560\u201315565 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2507_CR110","doi-asserted-by":"crossref","first-page":"20716","DOI":"10.1074\/jbc.M109.090845","volume":"285","author":"IS Daniels","year":"2010","unstructured":"Daniels, I.S. et al. A role of erythrocytes in adenosine monophosphate initiation of hypometabolism in mammals. J. Biol. Chem. 285, 20716\u201320723 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnm2507_CR111","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.1108581","volume":"308","author":"E Blackstone","year":"2005","unstructured":"Blackstone, E., Morrison, M. & Roth, M.B. H2S induces a suspended animation-like state in mice. Science 308, 518 (2005).","journal-title":"Science"},{"key":"BFnm2507_CR112","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/ALN.0b013e318167af0d","volume":"108","author":"GP Volpato","year":"2008","unstructured":"Volpato, G.P. et al. Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology 108, 659\u2013668 (2008).","journal-title":"Anesthesiology"},{"key":"BFnm2507_CR113","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1073\/pnas.0609611104","volume":"104","author":"BY Chin","year":"2007","unstructured":"Chin, B.Y. et al. Hypoxia-inducible factor 1a stabilization by carbon monoxide results in cytoprotective preconditioning. Proc. Natl. Acad. Sci. USA 104, 5109\u20135114 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2507_CR114","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.RES.0000250174.31269.70","volume":"99","author":"HK Eltzschig","year":"2006","unstructured":"Eltzschig, H.K. et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ. Res. 99, 1100\u20131108 (2006).","journal-title":"Circ. Res."},{"key":"BFnm2507_CR115","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.20030891","volume":"198","author":"HK Eltzschig","year":"2003","unstructured":"Eltzschig, H.K. et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198, 783\u2013796 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnm2507_CR116","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.1132559","volume":"314","author":"Y Chen","year":"2006","unstructured":"Chen, Y. et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314, 1792\u20131795 (2006).","journal-title":"Science"},{"key":"BFnm2507_CR117","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood-2010-10-313957","volume":"117","author":"AK Riegel","year":"2011","unstructured":"Riegel, A.K. et al. Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood 117, 2548\u20132555 (2011).","journal-title":"Blood"},{"key":"BFnm2507_CR118","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1073\/pnas.0902531106","volume":"106","author":"W Peng","year":"2009","unstructured":"Peng, W. et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc. Natl. Acad. Sci. USA 106, 12489\u201312493 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2507_CR119","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/ALN.0b013e3181b060f2","volume":"111","author":"HK Eltzschig","year":"2009","unstructured":"Eltzschig, H.K. Adenosine: an old drug newly discovered. Anesthesiology 111, 904\u2013915 (2009).","journal-title":"Anesthesiology"},{"key":"BFnm2507_CR120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/blood-2008-06-165746","volume":"113","author":"HK Eltzschig","year":"2009","unstructured":"Eltzschig, H.K. et al. Central role of Sp1-regulated CD39 in hypoxia\/ischemia protection. Blood 113, 224\u2013232 (2009).","journal-title":"Blood"},{"key":"BFnm2507_CR121","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2004-06-2066","volume":"104","author":"HK Eltzschig","year":"2004","unstructured":"Eltzschig, H.K. et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104, 3986\u20133992 (2004).","journal-title":"Blood"},{"key":"BFnm2507_CR122","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1681\/ASN.2006101141","volume":"18","author":"A Grenz","year":"2007","unstructured":"Grenz, A. et al. Protective role of ecto-5\u2032-nucleotidase (CD73) in renal ischemia. J. Am. Soc. Nephrol. 18, 833\u2013845 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2507_CR123","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.4049\/jimmunol.0903617","volume":"186","author":"ML Hart","year":"2011","unstructured":"Hart, M.L. et al. Hypoxia-inducible factor-1a-dependent protection from intestinal ischemia\/reperfusion injury involves ecto-5\u2032-nucleotidase (CD73) and the A2B adenosine receptor. J. Immunol. 186, 4367\u20134374 (2011).","journal-title":"J. Immunol."},{"key":"BFnm2507_CR124","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1096\/fj.07-103911","volume":"22","author":"ML Hart","year":"2008","unstructured":"Hart, M.L. et al. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J. 22, 2784\u20132797 (2008).","journal-title":"FASEB J."},{"key":"BFnm2507_CR125","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.4049\/jimmunol.0901851","volume":"184","author":"ML Hart","year":"2010","unstructured":"Hart, M.L., Gorzolla, I.C., Schittenhelm, J., Robson, S.C. & Eltzschig, H.K. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J. Immunol. 184, 4017\u20134024 (2010).","journal-title":"J. Immunol."},{"key":"BFnm2507_CR126","doi-asserted-by":"crossref","unstructured":"Colgan, S.P. & Eltzschig, H.K. Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu. Rev. Physiol. doi:10.1146\/annurev-physiol-020911\u2013153230 (19 September 2011).","DOI":"10.1146\/annurev-physiol-020911-153230"},{"key":"BFnm2507_CR127","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","volume":"414","author":"A Ohta","year":"2001","unstructured":"Ohta, A. & Sitkovsky, M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916\u2013920 (2001).","journal-title":"Nature"},{"key":"BFnm2507_CR128","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1172\/JCI114547","volume":"85","author":"BN Cronstein","year":"1990","unstructured":"Cronstein, B.N., Daguma, L., Nichols, D., Hutchison, A.J. & Williams, M. The adenosine\/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J. Clin. Invest. 85, 1150\u20131157 (1990).","journal-title":"J. Clin. Invest."},{"key":"BFnm2507_CR129","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.4049\/jimmunol.0802193","volume":"182","author":"ML Hart","year":"2009","unstructured":"Hart, M.L., Jacobi, B., Schittenhelm, J., Henn, M. & Eltzschig, H.K. Cutting edge: A2B adenosine receptor signaling provides potent protection during intestinal ischemia\/reperfusion injury. J. Immunol. 182, 3965\u20133968 (2009).","journal-title":"J. Immunol."},{"key":"BFnm2507_CR130","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1371\/journal.pmed.0050137","volume":"5","author":"A Grenz","year":"2008","unstructured":"Grenz, A. et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 5, e137 (2008).","journal-title":"PLoS Med."},{"key":"BFnm2507_CR131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clim.2011.03.002","volume":"140","author":"JJ Field","year":"2011","unstructured":"Field, J.J., Nathan, D.G. & Linden, J. Targeting iNKT cells for the treatment of sickle cell disease. Clin. Immunol. 140, 177\u2013183 (2011).","journal-title":"Clin. Immunol."},{"key":"BFnm2507_CR132","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3565(24)29370-8","volume":"298","author":"Z Gao","year":"2001","unstructured":"Gao, Z. et al. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J. Pharmacol. Exp. Ther. 298, 209\u2013218 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnm2507_CR133","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.jacc.2005.05.097","volume":"46","author":"RC Hendel","year":"2005","unstructured":"Hendel, R.C. et al. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J. Am. Coll. Cardiol. 46, 2069\u20132075 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnm2507_CR134","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/ajhp\/65.10.890","volume":"65","author":"CA Thompson","year":"2008","unstructured":"Thompson, C.A. FDA approves pharmacologic stress agent. Am. J. Health Syst. Pharm. 65, 890 (2008).","journal-title":"Am. J. Health Syst. Pharm."},{"key":"BFnm2507_CR135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nm0111-38","volume":"17","author":"MT Gladwin","year":"2011","unstructured":"Gladwin, M.T. Adenosine receptor crossroads in sickle cell disease. Nat. Med. 17, 38\u201340 (2011).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR136","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nm.2280","volume":"17","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat. Med. 17, 79\u201386 (2011).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR137","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1174381","volume":"324","author":"A Bonauer","year":"2009","unstructured":"Bonauer, A. et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710\u20131713 (2009).","journal-title":"Science"},{"key":"BFnm2507_CR138","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nm.2282","volume":"17","author":"JX Wang","year":"2011","unstructured":"Wang, J.X. et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med. 17, 71\u201378 (2011).","journal-title":"Nat. Med."},{"key":"BFnm2507_CR139","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.20101547","volume":"208","author":"L Qian","year":"2011","unstructured":"Qian, L. et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med. 208, 549\u2013560 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm2507_CR140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","volume":"327","author":"RE Lanford","year":"2010","unstructured":"Lanford, R.E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198\u2013201 (2010).","journal-title":"Science"},{"key":"BFnm2507_CR141","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrd3228","volume":"9","author":"R Motterlini","year":"2010","unstructured":"Motterlini, R. & Otterbein, L.E. The therapeutic potential of carbon monoxide. Nat. Rev. Drug Discov. 9, 728\u2013743 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm2507_CR142","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0037-1963(01)90027-7","volume":"38","author":"MT Gladwin","year":"2001","unstructured":"Gladwin, M.T. & Schechter, A.N. Nitric oxide therapy in sickle cell disease. Semin. Hematol. 38, 333\u2013342 (2001).","journal-title":"Semin. Hematol."},{"key":"BFnm2507_CR143","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","volume":"6","author":"C Szabo","year":"2007","unstructured":"Szabo, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6, 917\u2013935 (2007).","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2507","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:38:53Z","timestamp":1741887533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":143,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFnm2507"],"URL":"https:\/\/doi.org\/10.1038\/nm.2507","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}